Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Could artificial intelligence revolutionize the development of nanovectors for gene therapy and mRNA vaccines? — Akbar Hasanzadeh (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Could artificial intelligence revolutionize the development of nanovectors for gene therapy and mRNA vaccines?
Shared by
Michael R Hamblin
Could artificial intelligence revolutionize the development of nanovectors for gene therapy and mRNA vaccines?
Article
2022
en
Authors
+4 more
AH
Akbar Hasanzadeh
Michael R Hamblin
JK
Jafar Kiani
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Chapter in a book
2023
Spatially-Aware Artificial Intelligence for Sustainable Development Goals
Munir Ahmad
Chapter in a book
2023
Artificial Intelligence and Machine Learning Approach for Development and Discovery of Drug
Shweta Kumari
,
Akhalesh Kumar
,
Pawan Kumar Upadhyay
,
Ruchi Singh
,
Sudhanshu Mishra
,
Smriti Ojha
,
Neeraj Kumar
Article
2019
Using Artificial Intelligence to Improve the Quality and Safety of Radiation Therapy
Malvika Pillai
,
Karthik Adapa
,
Shiva K. Das
,
Łukasz Mazur
,
John Dooley
,
Lawrence B. Marks
,
Reid F. Thompson
,
Bhishamjit S. Chera
Article
2025
Using Artificial Intelligence to Improve the Quality and Safety of Radiation Therapy
Lawrence B. Marks
,
Łukasz Mazur
,
Malvika Pillai
,
Reid F. Thompson
,
Karthik Adapa
,
Bhishamjit S. Chera
,
John Dooley
,
Shiva K. Das
Article
2019
Comparison of DNA and mRNA vaccines against cancer
Zohreh Jahanafrooz
,
Behzad Baradaran
,
Jafar Mosafer
,
Mahmoud Hashemzaei
,
Tayebeh Rezaei
,
Ahad Mokhtarzadeh
,
Michael R Hamblin
Discussion(0)
No comments yet. Be the first to comment.